greekenglish
     Home arrow  Medical Service arrow Medical Service arrow Papers in foreign language magazines        

Login Form

Username

Password

Remember me
Password Reminder
No account yet? Create one
Papers in foreign language magazines

 


1.1.Independent predictors of failure of shockwave lithotripsy for ureteral stones employing a second-generation lithotriprer.
D.Delakas,I.Karyotis,G.Daskalopoulos,E.Lianos,E.Mauromanolakis.
J of Endourol 2003, 17: 201-205.

1.2.Membrane androgen binding sites are preferentially expressed in human prostate carcinoma cells.
E.Stathopoulos,C.Dambaki,M.Kampa,P.Theodoropoulos,P.Anezinis,D.Delakas,G.Delides,
E.Castanas.
BMC Clinical Pathology 2003,3: 1-9.

1.3.Symptomatic relief of patients with advanced bladder carcinoma after regional
Intra-arterial chemotherapy.
E.Mantadakis,C.Panagiotidis,D.Delakas,G.Samonis
Anticancer Res 2003, 23(6D): 5143-7.

1.4.Spontaneous perirenal hemorrhage:A 10-year experience at our institution.
G.Daskalopoulos,I.Karyotis,I.Heretis,P.Anezinis,E.Mavromanolakis,D.Delakas
Internat Urol & Nephrol 2004,36: 15-19.

1.5.Electrothermal bipolar coagulation for radical prostatectomies and cystectomies: A preliminary case-controlled study.
G.Daskalopoulos,I.Karyotis,I.Heretis,P.Anezinis,D.Delakas
Internat Urol & Nephrol 2004,36: 181-185.

1.6.Deregulation of p73 isoform equilibrium in benign prostate hyperplasia and prostate cancer.
D.Arvanitis,E.Lianos,N.Soulitzis,D.Delakas,D.Spandidos
Oncology Rep 2004,12:1131-1137.

1.7.Expression analysis of peptide growth factors VEGF, FGF2, TGFB1,EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.
N.Soulitzis, I.Karyotis, D.Delakas, D.A. Spandidos
Inter J of Oncol 2006,29: 305-314.

1.8. Μediterranean diet,mononsuturated:saturated`fat ratio and low prostate cancer risk. A myth or a reality?
K.Stamatiou,D.Delakas,F.Sofras
Min Urol & Nefrol 2007,59(1):59-66.

1.9. Pheochromocytoma of the urinary bladder: Report of two cases and review of the literature.
A.Siatelis,C.Konstantinidis,D.Volanis,P.Melidis,V.Leontara,E.Thoma-Tsagli,D.Delakas
Min Urol & Nefrol 2008,60:1-4.

1.10. Post-coital high-flow priapism treated with superselective microcoil embolization
Konstantinidis C,Gekas A,Papatsoris A,KartsaklisP,MourikisD,Delakas D,Sofikitis N
Gaz Med Ital 2010,169:19-21

1.11. Urothelial carcinoma of the sarcomatoid variant in a young patient with spina bifida:a case report and review of the literature
M Nomikos,P Phillipou,C Glava,D Delakas
Cases J 2009,2:9381

1.12. Transrectal Ultrasound-Guided Needle Aspiration of a prostatic Abscess
M Nomikos,I Karyotis,D Volanis,D Delakas
UroToday Inter J 2009,2(6):1944

1.13. Environmental factors and genetic susceptibility promote urinary bladder cancer
D Volanis,T Kadiyska,A Galanis,D Delakas, S Logotheti
Tox Lett 2010,15:193(2):131-7

1.14. Mutational Analysis of the BRAF gene in transitional cell carcinoma of the bladder
I Boulalas,A Zaravinos,D Delakas,D Spandidos
Inter J Biol Mark 2009,24(1):17-21

1.15. Safety of Ultrasound-Guided Transrectal Extended Prostate Biopsy in Patients Receiving Low-dose Aspirin
I Kariotis,P Philippou,D Volanis,E Serafetinides,D Delakas
Inter Br J Urol 2010,36(3):

1.16. Implication of RAF and RKIP Genes in Urinary Bladder Cancer
A Zaravinos,M Chatziioannou,G Lambrou,I Boulalas,D Delakas,D Spandidos
Pathol Oncol Res 2010,

1.17. Plasmacytoid Urothelial Carcinoma of the Bladder: A Rare Malignancy
P Philippou,I Kariotis,D Volanis,A Ploumidis,D Delakas
Urol Inter 2010,

1.18. Prospective Comparative Study of Endoscopic Management OF Bladder Lithiasis:Is Prostate Surgery a Necessary Adjunct?
P Philippou,D Volanis,I Kariotis,E Serafetinides,D Delakas
Urol 2010,

1.19. Statins and prostate cancer:Molecular and clinical aspects
G Papadopoulos,D Delakas,L Nakopoulou,T Kassimatis
Eur JC 2011,

1.20. Activation of RAS Family Genes in Urothelial Carcinoma
I Boulalas,A Zaravinos,I Karyotis,D Delakas,D Spandidos
J Urol 2009,

1.21.Identification of common differentially expressed genes in urinary bladder cancer
A Zaravinos,G Lambrou,I Boulalas,D Delakas,D Spandidos
PLos ONE 2011,6(4):e18135-1-28

1.22.Spotlight on differentially expressed genes in urinary bladder cancer
A Zaravinos,G Lambrou,D Volanis,D Delakas,D Spandidos
PLos ONE 2011,5(6):4,e 18255

1.23. Implication of RAF and RKIP Genes in Urinary Bladder Cancer
A. Zaravinos,M. Chatziioannou,G. Lambrou,I. Boulalas,D. Delakas, D.A. Spandidos
Pathol Oncol Res 2011,17:181-190

1.24. mRNA expression of G(1)-phase cell cycle regulatory molecules in bladder cancer.
Pantazis E,Soulitzis N,Soufla G,Karyotis I,Delakas D,Spandidos DA
J BUON 2011,16(2):323-30

1.25. Expression profile of Rho kinases in urinary bladder cancer
Volanis D, Zaravinos A, Kadiyska T,Delakas D,Spandidos DA
J BUON 2011,16(3):511-521.

1.26. A Computational model for tumor cell membrane tolerance and rigidy limits
G Lambrou,A Zaravinos,M Adamaki,D Delakas,S Vlahopoulos
Proccedings of 10th Inter Workshop on Biomedical Engineering.Kos,5-7 Oct 2011

1.27. Molecular mechanisms in urinary bladder carcinogenesis
Volanis D, Papadopoulos G,Doumas K, Gkialas I,Delakas D
J Buon 2011;16(4):589-601

1.28. Post-esw lithotripsy residual stone fragments:clinical significance and management
O Porfyris,D Delakas
Scand J Urol & Nephrol 2012;early online,1-8

1.29. Expression of miRNAs involved in angiogenesis,tumor cell proliferation,tumorauppressor inhibition,epithelial-mesenchymal
transition and activation of metastasis in bladder cancer
A Zaravinos,J Radosicic,G Lambrou,D Volanis,D Delakas,N Stathopoulos,DA Spandidos
J Urol 2012,188(2):615-623

1.30. Role of the angiogenic components, VEGFA,FGF2,OPN and RHOC,in urothelial cell carcinoma of the urinary bladder
Zaravinos A,Volanis D,Lambrou G,Delakas D,Spandidos D
Oncol Rep 2012,28(4):1159-1166

1.31. Association of human herpes,papilloma virus families with bladder cancer
Panagiotakis G,Papadogianni D,Chatziijoannou M,Lasithiotaki I,Delakas D,Spandidos D
Tumour Biol 2012,13:
IT Asklepieio Voulas
Number of Visitors